Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lindsey W. Eichinger"'
Autor:
Jennifer A Calvo, Catherine A Moroski-Erkul, Annabelle Lake, Lindsey W Eichinger, Dharini Shah, Iny Jhun, Prajit Limsirichai, Roderick T Bronson, David C Christiani, Lisiane B Meira, Leona D Samson
Publikováno v:
PLoS Genetics, Vol 9, Iss 4, p e1003413 (2013)
Alkylating agents comprise a major class of front-line cancer chemotherapeutic compounds, and while these agents effectively kill tumor cells, they also damage healthy tissues. Although base excision repair (BER) is essential in repairing DNA alkylat
Externí odkaz:
https://doaj.org/article/a39d82084ef4473aad559c7a922ea40b
Autor:
Selene Howe, Daniel T. Dransfield, Lampe John W, Kim Stickland, Neil A. Farrow, Dorothy Brach, Kenneth W. Duncan, Suzanne L. Jacques, Allison Drew, Lindsey W. Eichinger, Vinny Motwani, Alejandra Raimondi, Cuyue Tang, Chloe Pantano
Publikováno v:
Cancer Research. 80:2924-2924
SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily A member 2 (SMARCA2) is an ATP-dependent DNA helicase and a catalytic component of the SWI/SNF complex. SWI/SNF-mediated nucleosome remodeling is a critical regulato
Autor:
Allison E. Drew, Suzanne L. Jacques, Lindsey W. Eichinger, Chloe Pantano, Vinny Motwani, Cuyue Tang, Neil Farrow, Dorothy Brach, Selene Howe, Alejandra Raimondi, Daniel T. Dransfield, Kenneth W. Duncan, Kim Stickland, Liyue Huang, John Lampe
Publikováno v:
Cancer Research. 80:1768-1768
SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily A member 2 (SMARCA2) is an ATP-dependent DNA helicase and a catalytic component of the SWI/SNF complex. SWI/SNF-mediated nucleosome remodeling is a critical regulato
Autor:
Lauren Moran, Wei-Sheng Huang, Yaoyu Ning, Dong Zou, Scott Wardwell, Emily Y. Ye, Frank Wang, Rachel M. Squillace, Lindsey W. Eichinger, Victor M. Rivera, Jeff Keats, Sen Zhang, William C. Shakespeare, Yihan Wang, Sara Nadworny, Shuangying Liu, Tianjun Zhou, Youngchul Song, Xiaotian Zhu, Tim Clackson, David Miller, Hyun Gyung Jang, Narayana I. Narasimhan, Rana Anjum, David C. Dalgarno, Qurish K. Mohemmad, Juan J. Miret
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 22(22)
Purpose: Non–small cell lung cancers (NSCLCs) harboring ALK gene rearrangements (ALK+) typically become resistant to the first-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) crizotinib through development of secondary r
Publikováno v:
Cancer Research. 78:807-807
The EZH2 inhibitor tazemetostat (EPZ-6438) is currently being evaluated in phase 2 clinical trials for the treatment of non-Hodgkin lymphoma (NHL). EZH2 inhibitors have shown anti-proliferative effects in multiple preclinical models of NHL, mesotheli
Autor:
Iny Jhun, Roderick T. Bronson, David C. Christiani, Leona D. Samson, Lisiane B. Meira, Prajit Limsirichai, Lindsey W. Eichinger, Dharini Shah, Catherine A. Moroski-Erkul, Jennifer A. Calvo, Annabelle Lake
Publikováno v:
PLoS
PLoS Genetics
PLoS Genetics, Vol 9, Iss 4, p e1003413 (2013)
PLoS Genetics
PLoS Genetics, Vol 9, Iss 4, p e1003413 (2013)
Alkylating agents comprise a major class of front-line cancer chemotherapeutic compounds, and while these agents effectively kill tumor cells, they also damage healthy tissues. Although base excision repair (BER) is essential in repairing DNA alkylat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c141ad92f4debcac3fcb768d67665360
http://hdl.handle.net/1721.1/79393
http://hdl.handle.net/1721.1/79393
Autor:
Koli Taghizadeh, Line M. Nordstrand, Sureshkumar Muthupalani, Arne Klungland, Chun-Yue I. Lee, Catherine A. Moroski-Erkul, Leona D. Samson, Lisiane B. Meira, Lindsey W. Eichinger, Jennifer A. Calvo, Nona Abolhassani
Publikováno v:
The Journal of clinical investigation. 122(7)
More than 15% of cancer deaths worldwide are associated with underlying infections or inflammatory conditions, therefore understanding how inflammation contributes to cancer etiology is important for both cancer prevention and treatment. Inflamed tis
Autor:
Scott Wardwell, Lindsey W. Eichinger, Biplab Das, Sen Zhang, J. Graeme Hodgson, Sara Nadworny, Victor M. Rivera, Emily Y. Ye
Publikováno v:
Cancer Research. 75:781-781
Background: Disease progression in anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients (pts) treated with the first-generation tyrosine kinase inhibitor (TKI) crizotinib, or the second-generation inhibitors ceritini